Impact of having a regular drug dealer on obtaining drug checking results consistent with expectations during a drug toxicity crisis in a Canadian setting
Esopenko H, Marshall BDL, Lysyshyn M, Grant C, Sherman SG, Wood E, Kerr T, Ti L., Drug Alcohol Depend. 2025
Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l’urine et l’usage autodéclaré dans le contexte d’un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l’usage d’opioïdes vendus sur ordonnance
Bastien G, Abboud A, McAnulty C, Mahroug A, Le Foll B, Socias ME, Juteau LC, Dubreucq S, Jutras-Aswad D., Can J Psychiatry. 2025
Exploring unregulated substance use health data in Ontario, Canada: Identifying gaps, addressing challenges, and uncovering opportunities
Ali, F., Law, J., Russell, C., Imtiaz, S., Bayoumi, A., Werb, D., Rhem, J., Front. Public Health
Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020
Jackson E, Bach P, Socias ME, Brooks OM, Fairbairn N, Rodrigues M, Rosic T, Naji L, Jinks-Chang S, Nolan S, Chesney A, Reshetukha T, Samaan Z, Dennis BB., Drug Alcohol Depend. 2025
Indigenous peoples and medications for opioid use disorders: A scoping review
Gala N, Dobischok S, Bernett P, Parker DG, O’Callahan A, Zentner D, Huson K, Tomaro J, Wendt DC., Psychol Addict Behav. 2025
Characterizing changes to harm reduction site operations in British Columbia following the implementation of the decriminalization of drugs: Findings from a provincial survey
Ali, F. , Russell,C., Law, J., Imtiaz, S., Budau, J., Shahin, R., MacKinnon, L., Griffith, S., Patenaude, S., Xavier, J., Rhem, J., Harm Reduction Journal
Capacity Building and Creating Supportive Environments for Inclusive Community-Based Participatory Research: A Case Study of the Overdose Prevention Peer Research Assistant (OPPRA) Project
Morgan J, Taylor T, Nolan S, Blais A, Cywink SL, Duguay JM, Gibbons TA, Maxwell S, Marsh S, Pratt M, Glegg S, Int J Qual Methods, 2025.
Physician perspectives on reducing harm and supporting emergency department patients who use drugs
Zoe K. D. Collins,Elaine Hyshka,Karine J. Lavergne,Savannah M. Weber,Ginetta Salvalaggio,Cindy Jiaxin Xue,Arlanna Pugh,Janusz Kaczorowski,Aaron M. Orkin,Andrew Kestler,Kathryn A. Dong, PLoS One
Comparative Effectiveness of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use Among People with Opioid Use Disorder in Canada
Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME., Subst Use Addctn J. 2025
Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people
Kira London‑Nadeau, Christian Barborini, Rebecca Haines‑Saah, Misha Bazarov, Sean Bristowe, Misha Khorkhordina, Mélodie Lemay‑Gaulin, Catherine Gorka, Robert‑Paul Juster, Heath D’Alessio, Nicholas Chadi, International Journal of Drug Policy, 2025
